WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical Research Act.

Boehringer's Hernexeos is now FDA-approved for patients with HER2-positive NSCLC, bringing it into direct competition with ADC Enhertu.

Biostar Stem Cell Technology Research Institute has received Japan's MHLW approval for its angel stem cell therapy for ASD.

Linked data could unlock essential hidden insights across healthcare – but linking has to be executed correctly to avoid ...

H1 sales growth for Novo Nordisk’s segment that includes Ozempic and Wegovy was down from the same period in 2024.

Spanning topics across R&D, clinical trials, and commercial launch, our podcast series continues as two clinical supplies ...

The FDA’s new PreCheck programme is aimed at facilitating the introduction of new US drug manufacturing facilities.

Primary packaging is never an afterthought in the world of injectable drugs, where systems such as vials, syringes, and auto-injectors are crucial to the administration of new products. But what ...

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation between the US and the EU.

The FDA has approved a label expansion to Teva’s Ajovy in certain children and adolescents, making it the first migraine prevention drug of its kind in the age group.

The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.